Physician profile
John Seccombe
NPI 1922026780
$16,050.23
in general payments reported to CMS, 2019-2025
20 companies · $560 in 2025
The $560 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,712 · 2020: $181 · 2021: $471 · 2022: $580 · 2023: $11K · 2024: $1,077 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $2,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,233.10 |
| Food and Beverage | $2,873.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,192.17 | 2021-2024 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,773.95 | 2019-2020 | |
| Edwards Lifesciences Corporation | $845.88 | 2021-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $674.70 | 2021-2025 | Impella |
| Livanova USA, INC. | $193.08 | 2022-2023 | Lifesparc |
| W. L. Gore & Associates, INC. | $179.68 | 2022-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Novartis Pharmaceuticals Corporation | $152.33 | 2019-2025 | |
| Abbott Laboratories | $135.41 | 2022-2024 | Pressurewire |
| Intuitive Surgical, INC. | $127.22 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.56 | 2019-2024 | Lifevest |
| Lilly USA, LLC | $121.18 | 2025 | |
| Penumbra, INC. | $113.61 | 2024 | Indigo System |
| Lemaitre Vascular, INC. | $100.60 | 2022-2023 | Artegraft Vascular Graft |
| Atricure, INC. | $88.99 | 2019 | |
| Prism Medical | $87.29 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $41.81 | 2023-2024 | Farxiga |
| Stryker Corporation | $29.04 | 2025 | Clottriever Bold Catheter |
| Cardiovascular Systems INC. | $26.12 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.82 | 2024 | Xarelto |
| Angiodynamics, INC. | $19.79 | 2023 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Seccombe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.